TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT): Study protocol for a pilot randomized controlled trial
PLOS One · 2026
DOI: 10.1371/journal.pone.0353841 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2026. Verfasst von Andrew D Meyer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Long School of Medicine at the University of Texas Health Science Center, San Antonio, Texas, United States of America. Hauptthemen laut MEDLINE: Tonsillectomy, Tranexamic Acid, Postoperative Hemorrhage, Antifibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, University of Texas Health Science Center at San Antonio.
Abstract (Originalsprache)
Tonsillectomy is the second most common performed surgical procedure in children in the United States. Unfortunately, up to five percent of children return to emergency departments (ED) for post-tonsillectomy hemorrhage (PTH). To control PTH, most pediatric otolaryngologists return to the operating room (OR) for cauterization of the bleeding source. Retrospective studies suggest that nebulized tranexamic acid (TXA), an antifibrinolytic agent, can reduce the severity of post-tonsillectomy hemorrhage (PTH), however, its efficacy and safety have not yet been tested in randomized controlled trials. We designed the TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT) trial protocol to evaluate the feasibility of conducting a confirmatory clinical trial to evaluate the effects of TXA in children with PTH. We will randomize children presenting to the ED with secondary PTH to receive three 5-mL nebulized doses of either TXA (TXA 100 mg/ml) or placebo (normal saline). The following outcomes will be measured: feasibility (number of enrolled patients per site per year); protocol adherence (receipt of at least two nebulization doses); return to the operating room; pain reported on the FACES scale; parent and child anxiety assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety measure; systemic and local (pharmacokinetic model derived) concentrations of nebulized TXA; coagulation biomarkers; and adverse events, including bleeding, thrombosis, and seizures. Our multicenter trial will provide important preliminary data on the feasibility and pharmacokinetics of nebulized TXA in preparation for a definitive clinical trial of children with secondary post-tonsillectomy hemorrhage. Registered at ClinicalTrials.gov ID# (NCT07565753) on May 4 th , 2026, https://clinicaltrials.gov/study/NCT07565753?term=teapot&viewType=Card&rank=1
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Long School of Medicine at the University of Texas Health Science Center, San Antonio, Texas, United States of America.
- Department of Emergency Medicine, Long School of Medicine at the University of Texas Health Science Center, San Antonio, Texas, United States of America.
- Department of Otolaryngology, Long School of Medicine at the University of Texas Health Science Center, San Antonio, Texas, United States of America.
- Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, United States of America.
- Department of Emergency Medicine, Rhode Island Hospital/Hasbro Children's Hospital and Brown University, Providence, Rhode Island, United States of America.
- Department of Emergency Medicine, UC Davis School of Medicine, Sacramento, California, United States of America.
ORCID-Profile: Andrew D Meyer, Thomas H Chun
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- University of Texas Health Science Center at San Antonio
Zitieren
APA
Meyer, A. D., Schwarz, W., Erwin, D., Earley, M., Yellepeddi, V. K., Chun, T. H., Casper, T. C., & Nishijima, D. K. (2026). TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT): Study protocol for a pilot randomized controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0353841
Vancouver
Meyer AD, Schwarz W, Erwin D, Earley M, Yellepeddi VK, Chun TH, et al. TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT): Study protocol for a pilot randomized controlled trial. PLOS One. 2026. doi:10.1371/journal.pone.0353841
BibTeX
@article{Meyer2026,
author = {Meyer, Andrew D and Schwarz, Whitney and Erwin, Dylan and Earley, Marisa and Yellepeddi, Venkata K and Chun, Thomas H and Casper, T Charles and Nishijima, Daniel K},
title = {TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT): Study protocol for a pilot randomized controlled trial},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0353841}
}
EUVIMED